Tracy Saxton co-founded Pivotal bioVenture Partners in 2017 and serves as its Managing Director. See contact routes.
Tracy Saxton co-founded Pivotal bioVenture Partners in 2017 and serves as its Managing Director, having previously worked as an investor at Roche Venture Fund and an advisor at SV Life Sciences. Her investment thesis targets early-stage biotechnology companies in discovery through Phase 1 testing, focusing on private therapeutics addressing unmet needs with a geographic emphasis on the U.S.. The firm plans to invest in roughly 15 to 18 biotechs per fund, though specific check sizes and whether Saxton typically leads or follows deals are not publicly detailed. Notable portfolio companies are not explicitly named in available sources, as the firm’s first investment announcement was expected shortly after its March 2017 fund close. Saxton holds a PhD in Molecular Genetics from the University of Toronto and an MBA from Columbia Business School, and she was a Damon Runyon-Walter Winchell Cancer Fund fellow at UCSF. There is no publicly available distinctive point of view or published writing by Saxton beyond her professional background and firm announcements.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in San Francisco.
Investors like Tracy Saxton · Full investor directory · Investor access · Company funding database